AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $169.01, with a market capitalization of 266.69B. The stock trades at a price-to-earnings (P/E) ratio of 25.61 and offers a dividend yield of 1.83%.
As of 2026-07-13, AstraZeneca(AZN) stock has fluctuated between $171.42 and $176.85. The current price stands at $169.01, placing the stock -1.4% above today's low and -4.4% off the high.
The AstraZeneca(AZN)'s current trading volume is 3.6M, compared to an average daily volume of 2.82M.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
AZN News
HSBC analyst Rajesh Kumar downgraded AstraZeneca (AZN) to Hold from Buy with a price target of 13,750 GBp, down from 16,500 GBp. The firm says the company’s pat...
...
Astrazeneca (NYSE:AZN) told investors and analysts that it is continuing to embed sustainability into its business strategy while updating some of its 2030 targ...
Analyst ratings
80%
of 30 ratingsMore AZN News
In the latest close session, Astrazeneca (AZN) was down 3.85% at $171.61. This move lagged the S&P 500's daily gain of 0.42%. Elsewhere, the Dow saw an upswing...
Icon Plc (ICLR), AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with Ti...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
Shares of BridgeBio Pharma BBIO climbed to a 52-week high of $93.42 on Thursday after rival AstraZeneca's AZN late-stage clinical setback boosted investor confi...
TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...
Canaccord analyst Gary Nachman lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $95 from $110 and keeps a Buy rating on the shares. The firm a...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.